US Drug Prices: Higher for Brand Names, Lower for Generics
Blog: Conversable Economist
Brand-name drugs in the United States cost more than in other countries. The primary reason is that the US has a sort-of-constrained but pretty free market in setting drug prices, while in other countries it is common for the government or national health service to give pharmaceutical companies what amounts to a take-it-or-leave-it offer: charge … Continue reading US Drug Prices: Higher for Brand Names, Lower for Generics
The post US Drug Prices: Higher for Brand Names, Lower for Generics first appeared on Conversable Economist.